TP53 and neuroblastoma: Although with the limitation of the little statistical power, these data provide support to a number of observations: (i) p53 is only rarely mutated in neuroblastoma (up to 15% after relapse and/or progression) suggesting that neuroblastoma has “an innate requirement for baseline p53 activity (perhaps to resist oncogenic stress)” as stated by Kim and Shohet (2009).